Cited by 157Treatment of Major DepressionNerve injury and regenerationBipolar Disorder and Treatment

Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression

Open access
Angelucci, Francesco, Aloe, Luigi, Jiménez-Vasquez, Patricia, Mathé, Aleksander A.·2003·The International Journal of Neuropsychopharmacology

Abstract

Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) are proteins involved in neuronal survival and plasticity of dopaminergic, cholinergic and serotonergic neurons in the central nervous system. Since decreased size and impaired function of some neuronal populations may be relevant in depression it has been hypothesized that these molecules may have a functional role in the pathophysiology as well as treatment of depression. Using an animal model of depression, the Flinders Sensitive Line (FSL) rats and their controls, the Flinders Resistant Line (FRL), we investigated the effects of chronic lithium treatment on brain NGF, BDNF and GDNF. Lithium was administered as food supplementation during 6 wk. NGF, BDNF and GDNF measurements were performed by enzyme-linked immunosorbent assay (ELISA). Lithium altered the brain concentrations of neurotrophic factors in the hippocampus, frontal cortex, occipital cortex and striatum. Moreover, the changes were different in the two rat strains. Our data support the notion that neurotrophic factors play a role in depression and in the mechanism of the action of lithium.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145703003468

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Lithium treatment in rats increases GDNF concentrations in the PFC and occipital cortex but decreases them in the hippocampus.

    “whereas lithium treatment in rats resulted in increased GDNF concentrations in the PFC and occipital cortex but a decrease in the hippocampus (Angelucci et al. 2003b).”

    From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Angelucci et al. 2003b

    The GDNF results and Discussion report increased concentrations in the frontal and occipital cortices and decreased concentrations in the hippocampus after lithium treatment. The reported changes were specifically in FRL rats, however, and the measured region is called the frontal cortex rather than the PFC; the citing sentence omits the strain restriction and uses a more specific anatomical label. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 15

  1. Angelucci F, Aloe L, Jime ´nez-Vasquez P, Mathe ´AA (2002a). Electroconvulsive stimuli alter the regional concentrations of NGF, BDNF and GDNF in adult rat brain. Journal of ECT 18, 138-143.
  2. Angelucci F, Mathe ´AA, Aloe L (2000b). Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. Journal of Neuroscience Research 60, 783-794.
  3. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS (2000). Hippocampal volume reduction in major depression. American Journal of Psychiatry 157, 115-118.
  4. Bohn MC, Kozlowski DA, Connor B (2000). Glial cell line-derived neurotrophic factor (GDNF) as a defensive molecule for neurodegenerative disease : a tribute to the studies of antonia vernadakis on neuronal-glial interactions. International Journal of Developmental Neuroscience 18, 679-684.
  5. Chen RW, Chuang DM (1999). Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. Journal of Biological Chemistry 274, 6039-6042.
  6. Duman RS, Vaidya VA (1998). Molecular and cellular actions of chronic electroconvulsive seizures. Journal of ECT 14, 181-193.
  7. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J (1989). Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. New England Journal of Medicine 321, 1489-1493.
  8. Glowinski J, Iversen LL (1965). Regional studies of catecholamines in the rat brain : the disposition of ( 3 H) norepinerphine, ( 3 H) dopamine and ( 3 H) dopa in various regions of the brain. Journal of Neurochemistry 13, 655-669.
  9. Krystal AD, Weiner RD (1999). EEG correlates of the response to ECT : a possible antidepressant role of brain-derived neurotrophic factor. Journal of ECT 15, 27-38.
  10. Lee J, Duan W, Mattson M (2002). Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. Journal of Neurochemistry 82, 1367-1375.
  11. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience 20, 9104 -9110.
  12. Mathe ´AA, Jousisto-Hanson J, Stenfors C, Theodorsson E (1990). Effect of lithium on tachykinins, calcitonin gene-related peptide, and neuropeptide Y in rat brain. Journal of Neuroscience Research 26, 233-237.
  13. Nawa H, Carnahan J, Gall C (1995). BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure : partial disagreement with mRNA levels. European Journal of Neuroscience 7, 1527-1535.
  14. Weskamp G, Otten U (1986). An enzyme-linked immuno- assay for nerve growth factor (NGF) : a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. Journal of Neurochemistry 48, 1779-1786.
  15. Zafra F, Castren E, Thoenen H, Lindholm D (1991). Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proceedings of the National Academy of Science USA 88, 10037-10041.

Cited by

Sorted by citations

Authors
Angelucci, F., Aloe, L., Jiménez-Vasquez, P., & Mathé, A. A.
Affiliations
  • Karolinska Institutet (SE)
  • Institute of Neurobiology and Molecular Medicine (IT)
Corresponding author
Mathé, Aleksander A.
Venue
The International Journal of Neuropsychopharmacology
Published
2003-09
Volume
6
Issue
3
Pages
225-231
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2135442608
Cited by
157
References
5
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 8 · 2016: 11 · 2015: 8 · 2014: 9 · 2013: 16 · 2012: 3
FWCI
3.95
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Karolinska Institutet
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
lithium, depression, nerve growth factor, brain-derived neurotrophic factor, glial cell line-derived neurotrophic factor, neurotrophic factors, Flinders Sensitive Line rats, rat strain differences, hippocampus, frontal cortex, occipital cortex, striatum
MeSH terms
Animals, Brain Chemistry, Depression, Enzyme-Linked Immunosorbent Assay, Lithium, Nerve Growth Factors, Rats, Inbred Strains, Antimanic Agents, Brain-Derived Neurotrophic Factor, Glial Cell Line-Derived Neurotrophic Factor, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review